文献
1. Wijns W, Kolh P, Danchin N, et al., European Association for Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization: The
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS). Eur Heart J 2010; 31: 2501-2555.
2. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronay artery disease: A meta-analysis.
Circulation 2005; 111: 2906-2912.
3. Boden WE, O’Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N
Engl J Med 2007; 356: 1506-1516.
4. Frye RL, August P, Brooks MM, et al., BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J
Med 2009; 360: 2503-2515.
5. Chaitman BR, Hardison RM, Adler D, et al., Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass
Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic
heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009; 120: 2529-2540.
6. Weintraub WS, Spertus JA, Kolm P, et al., COURAGE Trial Research Group. Effect of PCI on quality of life in patients with stable coronary disease.
Engl J Med 2008; 359: 677-687.
7. Nishigaki K, Yamazaki T, Kitabatake A, et al., Japanese Stable Angina Pectoris Study Investigators. Percutaneous coronary intervention plus medical
therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary
artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv 2008; 1: 469-479.
8. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive metaanalysis of randomized trials and
observational studies. Circulation 2009; 119: 3198-3206.
9. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year
synopsis and a network meta-analysis. Lancet 2009; 373: 911-918.
10. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by
the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570.
11. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period. N Engl
J Med 1996; 334: 216-219.
12. Taggart DP, D’Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single
internal mammary arteries. Lancet 2001; 358: 870-875.
13. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial
of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-1089.
14. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled
clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010; 122: 949-957.
15. Brooks MM, Chung SC, Helmy T, et al . Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group Health status after
treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Circulation 2010; 122: 1690-1699.
16. Gersh BJ, Frye RL. Methods of coronary revascularizationthings may not be as they seem. N Engl J Med 2005; 352: 2235-2237.
17. Serruys PW, Morice MC, Kappetein AP, et al., SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for
severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
18. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or
three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32:2125-2134.
19. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel
disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-1197.
20. Kimura T, Morimoto T, Furukawa Y, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for
multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118[suppl]: S199-S209.
21. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358:
331-341.
22. Marui A, Kimura T, Tanaka S, et al. and on behalf of the CREDO-Kyoto Investigatiors. Siginificance of off-pump coronary artery bypass grafting
compared with percutaneous coronary intervention: a propensity score analysis. Eur JCardiothorac Surg 2012;41:94-101.
23. Park SJ, Kim YH, Park DW, et al. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 2011; 364: 1718-
1727.
24. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of
the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of
Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed
by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
Circulation 2009; 119: 1330-1352.
25. Kushner FG, Hand M, Smith SC Jr, et al., American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009
Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007
Focused Update) and ACC/AHA/SCAI Guidel ines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a
report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-
2306.
26. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, et al Three-year outcomes af ter si rol imus-elut ing stent implantation for unprotected left main coronary
artery disease-Insights from the j-cypher registry. Circulation 2009; 120: 1866-1187. 13
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS). Eur Heart J 2010; 31: 2501-2555.
2. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronay artery disease: A meta-analysis.
Circulation 2005; 111: 2906-2912.
3. Boden WE, O’Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N
Engl J Med 2007; 356: 1506-1516.
4. Frye RL, August P, Brooks MM, et al., BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J
Med 2009; 360: 2503-2515.
5. Chaitman BR, Hardison RM, Adler D, et al., Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass
Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic
heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009; 120: 2529-2540.
6. Weintraub WS, Spertus JA, Kolm P, et al., COURAGE Trial Research Group. Effect of PCI on quality of life in patients with stable coronary disease.
Engl J Med 2008; 359: 677-687.
7. Nishigaki K, Yamazaki T, Kitabatake A, et al., Japanese Stable Angina Pectoris Study Investigators. Percutaneous coronary intervention plus medical
therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary
artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv 2008; 1: 469-479.
8. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive metaanalysis of randomized trials and
observational studies. Circulation 2009; 119: 3198-3206.
9. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year
synopsis and a network meta-analysis. Lancet 2009; 373: 911-918.
10. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by
the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570.
11. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period. N Engl
J Med 1996; 334: 216-219.
12. Taggart DP, D’Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single
internal mammary arteries. Lancet 2001; 358: 870-875.
13. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial
of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007; 115: 1082-1089.
14. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled
clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010; 122: 949-957.
15. Brooks MM, Chung SC, Helmy T, et al . Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group Health status after
treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Circulation 2010; 122: 1690-1699.
16. Gersh BJ, Frye RL. Methods of coronary revascularizationthings may not be as they seem. N Engl J Med 2005; 352: 2235-2237.
17. Serruys PW, Morice MC, Kappetein AP, et al., SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for
severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
18. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or
three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32:2125-2134.
19. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel
disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-1197.
20. Kimura T, Morimoto T, Furukawa Y, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for
multivessel coronary artery disease in the bare-metal stent era. Circulation 2008; 118[suppl]: S199-S209.
21. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358:
331-341.
22. Marui A, Kimura T, Tanaka S, et al. and on behalf of the CREDO-Kyoto Investigatiors. Siginificance of off-pump coronary artery bypass grafting
compared with percutaneous coronary intervention: a propensity score analysis. Eur JCardiothorac Surg 2012;41:94-101.
23. Park SJ, Kim YH, Park DW, et al. Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 2011; 364: 1718-
1727.
24. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of
the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of
Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed
by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
Circulation 2009; 119: 1330-1352.
25. Kushner FG, Hand M, Smith SC Jr, et al., American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009
Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007
Focused Update) and ACC/AHA/SCAI Guidel ines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a
report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271-
2306.
26. Toyofuku M, Kimura T, Morimoto T, Hayashi Y, et al Three-year outcomes af ter si rol imus-elut ing stent implantation for unprotected left main coronary
artery disease-Insights from the j-cypher registry. Circulation 2009; 120: 1866-1187. 13
- Home
- 文献
虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン
（2011年改訂版）
Guidelines for the Clinical Application of Bypass Grafts and the Surgical Techniques（ JCS 2011）
（2011年改訂版）
Guidelines for the Clinical Application of Bypass Grafts and the Surgical Techniques（ JCS 2011）